Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

UK to expedite drug trials post-Brexit -FT

Drugmakers will be offered fast-tracked approvals for innovative medicines in the UK, in an effort to attract investments from life sciences companies post-Brexit, the Financial Times https://on.ft.com/3nDXS0q reported on Sunday.

Companies that promise to treat unmet medical needs will be offered help through the development process, including manufacturing, the newspaper said, citing three people familiar with the matter.

Companies are set to be offered the same rolling review of data that expedited approval of the Pfizer Inc and BioNTech COVID-19 vaccine under the so-called Innovative Licensing and Access Pathway, the FT reported.

(Reporting by Vishal Vivek in Bengaluru; Editing by Peter Cooney)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.